VSL#3 can prevent ulcerative colitis-associated carcinogenesis in mice

doi:10.3748/wjg.v24.i37.4254

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 24, Issue 37

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (12757)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-6) series, Tables (1-5) series.

Item

Count

PDF

850

WORD

314

HTML

8383

Figures (1-6)

306

Tables (1-5)

171

Sum=10024

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1332

Download

1401

Sum=2733

Oct 7, 2018 (publication date) through Apr 24, 2024

Times Cited of This Article

Times Cited (99)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastroenterol. Oct 7, 2018; 24(37): 4254-4262
Published online Oct 7, 2018. doi: 10.3748/wjg.v24.i37.4254

Full Size Figure Download Figure

Figure 1 Experimental protocol for ulcerative colitis-associated carcinogenesis model and treatment.

Citation: Wang CSE, Li WB, Wang HY, Ma YM, Zhao XH, Yang H, Qian JM, Li JN. VSL#3 can prevent ulcerative colitis-associated carcinogenesis in mice. World J Gastroenterol 2018; 24(37): 4254-4262
URL: https://www.wjgnet.com/1007-9327/full/v24/i37/4254.htm
DOI: https://dx.doi.org/10.3748/wjg.v24.i37.4254